HealthStream, Inc. $HSTM Shares Sold by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. trimmed its holdings in shares of HealthStream, Inc. (NASDAQ:HSTM) by 74.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 86,602 shares of the technology company’s stock after selling 256,522 shares during the period. Harbor Capital Advisors Inc. owned 0.29% of HealthStream worth $2,446,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Nuveen LLC acquired a new position in shares of HealthStream during the first quarter worth about $2,380,000. Russell Investments Group Ltd. raised its holdings in shares of HealthStream by 152.1% during the 1st quarter. Russell Investments Group Ltd. now owns 19,368 shares of the technology company’s stock valued at $622,000 after buying an additional 11,685 shares during the period. American Century Companies Inc. lifted its position in HealthStream by 9.6% during the 1st quarter. American Century Companies Inc. now owns 52,445 shares of the technology company’s stock worth $1,688,000 after acquiring an additional 4,613 shares in the last quarter. Northern Trust Corp boosted its holdings in HealthStream by 26.0% in the 1st quarter. Northern Trust Corp now owns 386,127 shares of the technology company’s stock worth $12,426,000 after acquiring an additional 79,687 shares during the period. Finally, Hsbc Holdings PLC boosted its holdings in HealthStream by 13.8% in the 1st quarter. Hsbc Holdings PLC now owns 47,824 shares of the technology company’s stock worth $1,535,000 after acquiring an additional 5,803 shares during the period. 69.58% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at HealthStream

In other HealthStream news, Director Tate Deborah Taylor sold 1,580 shares of the stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $25.46, for a total transaction of $40,226.80. Following the transaction, the director owned 23,127 shares of the company’s stock, valued at $588,813.42. This trade represents a 6.39% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CTO Jeff Cunningham sold 2,100 shares of the business’s stock in a transaction that occurred on Wednesday, December 10th. The shares were sold at an average price of $24.09, for a total value of $50,589.00. Following the completion of the sale, the chief technology officer owned 31,489 shares of the company’s stock, valued at $758,570.01. This trade represents a 6.25% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 5,680 shares of company stock worth $139,336 over the last quarter. 20.50% of the stock is owned by corporate insiders.

HealthStream Price Performance

HSTM opened at $23.83 on Friday. The stock has a market capitalization of $707.04 million, a PE ratio of 35.04, a P/E/G ratio of 2.90 and a beta of 0.45. The firm’s fifty day moving average price is $24.92 and its 200 day moving average price is $26.52. HealthStream, Inc. has a 12-month low of $23.61 and a 12-month high of $34.24.

HealthStream (NASDAQ:HSTM) last announced its quarterly earnings data on Monday, November 3rd. The technology company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.03. The company had revenue of $76.47 million during the quarter, compared to analyst estimates of $75.52 million. HealthStream had a net margin of 6.93% and a return on equity of 5.82%. On average, equities research analysts forecast that HealthStream, Inc. will post 0.63 earnings per share for the current fiscal year.

HealthStream declared that its board has initiated a share buyback program on Tuesday, November 11th that allows the company to repurchase $10.00 million in outstanding shares. This repurchase authorization allows the technology company to repurchase up to 1.3% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board believes its stock is undervalued.

HealthStream Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 28th. Investors of record on Monday, November 17th were issued a $0.031 dividend. This represents a $0.12 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend was Monday, November 17th. HealthStream’s payout ratio is currently 17.65%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of HealthStream in a research note on Wednesday, October 8th. Wall Street Zen downgraded shares of HealthStream from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Finally, Canaccord Genuity Group reissued a “hold” rating and issued a $28.00 price objective on shares of HealthStream in a research report on Wednesday, December 17th. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $28.00.

HealthStream Company Profile

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company’s core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.